Artificial Intelligence-adjudicated Spatio-Temporal Dispersion: A Patient-unique Fingerprint of Persistent Atrial Fibrillation.

Artificial intelligence atrial fibrillation catheter ablation drivers mapping spatiotemporal dispersion

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 05 07 2023
revised: 27 12 2023
accepted: 06 01 2024
medline: 13 1 2024
pubmed: 13 1 2024
entrez: 12 1 2024
Statut: aheadofprint

Résumé

Spatiotemporal dispersion-guided ablation is a tailored approach for patients in persistent atrial fibrillation (AF). The characterization of dispersion extent and distribution and its association with common clinical descriptors of persistent AF (PsAF) patients have not been studied. Artificial intelligence-adjudicated dispersion extent and distribution (AI-DED) was obtained with a machine/deep learning classifier (VX1 software, Volta Medical) in PsAF patients undergoing ablation. We tested the hypothesis that AI-DED is unique to each patient and independent of common procedural and clinical parameters. In a sub-analysis of the Ev-AIFib study (NCT03434964), spatiotemporal dispersion maps were built with VX1 software in 78 consecutives persistent and long-standing persistent AF patients and AI-DED was quantified using two distinct approaches (visual regional characterization or automated global quantification of AI-DED). AI-DED paired-sub-region Euclidean distance measurements between 78 patients (average distance = 5.07 ± 0.60; min = 2.23 and max = 9.75) demonstrate that AI-DED is a patient-unique characteristic of PsAF. Importantly, both AF type and AF history do not correlate with AI-DED levels (R The atrial distribution and extent of multipolar electrogram spatio-temporal dispersion follows a non-random, albeit patient-unique, distribution in PsAF patients. As such, AI-DED may represent a procedure-implementable fingerprint of the PsAF substrate.

Sections du résumé

BACKGROUND BACKGROUND
Spatiotemporal dispersion-guided ablation is a tailored approach for patients in persistent atrial fibrillation (AF). The characterization of dispersion extent and distribution and its association with common clinical descriptors of persistent AF (PsAF) patients have not been studied.
OBJECTIVES OBJECTIVE
Artificial intelligence-adjudicated dispersion extent and distribution (AI-DED) was obtained with a machine/deep learning classifier (VX1 software, Volta Medical) in PsAF patients undergoing ablation. We tested the hypothesis that AI-DED is unique to each patient and independent of common procedural and clinical parameters.
METHODS METHODS
In a sub-analysis of the Ev-AIFib study (NCT03434964), spatiotemporal dispersion maps were built with VX1 software in 78 consecutives persistent and long-standing persistent AF patients and AI-DED was quantified using two distinct approaches (visual regional characterization or automated global quantification of AI-DED).
RESULTS RESULTS
AI-DED paired-sub-region Euclidean distance measurements between 78 patients (average distance = 5.07 ± 0.60; min = 2.23 and max = 9.75) demonstrate that AI-DED is a patient-unique characteristic of PsAF. Importantly, both AF type and AF history do not correlate with AI-DED levels (R
CONCLUSIONS CONCLUSIONS
The atrial distribution and extent of multipolar electrogram spatio-temporal dispersion follows a non-random, albeit patient-unique, distribution in PsAF patients. As such, AI-DED may represent a procedure-implementable fingerprint of the PsAF substrate.

Identifiants

pubmed: 38215808
pii: S1547-5271(24)00018-3
doi: 10.1016/j.hrthm.2024.01.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Julien Seitz (J)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France. Electronic address: julienseitz13008@gmail.com.

Théophile Mohr Durdez (TM)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Sabine Lotteau (S)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Clément Bars (C)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

André Pisapia (A)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Edouard Gitenay (E)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Jacques Monteau (J)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Mélanie Reist (M)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Meryem Serdi (M)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Amélie Dayot (A)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Michel Bremondy (M)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Mohamed Benadel (M)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Sabrina Siame (S)

St. Joseph Hospital, 26 Bd de Louvain 13008 Marseille, France.

Anthony Appetiti (A)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Paola Milpied (P)

Volta Medical, 65 avenue Jules Cantini, 13006 Marseille, France.

Jérôme Kalifa (J)

Brown University, Providence, Rhode Island, USA.

Classifications MeSH